Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-D-mannuronic acid in breast cancer patients
IRCT2017012213739N7Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of D-mannuronic acid in breast cancer, sponsored by Tehran University of Medical Sciences. Started Feb 2017; status: completed.
02
Drugs
D-mannuronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT2017012213739N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017012213739N7.